BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3836823)

  • 21. Comparison of antigenic sources for acetylcholine receptor antibody assays in myasthenia gravis.
    McAdams MW; Roses AD
    Ann Neurol; 1980 Jul; 8(1):61-6. PubMed ID: 6773466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specificities of antibody to acetylcholine receptor in rabbits with experimental myasthenia gravis.
    Ueno S; Kang J; Takeuchi H; Takahashi M; Tarui S
    Clin Exp Immunol; 1980 Jul; 41(1):13-8. PubMed ID: 6777100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acetylcholine receptor antibodies in myasthenia gravis].
    Yakirevich V; Snir E; Brener T; Borenstein N; Vidne BA
    Harefuah; 1983 Apr; 104(7):269-70. PubMed ID: 6618324
    [No Abstract]   [Full Text] [Related]  

  • 25. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
    Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency of seronegativity in adult-acquired generalized myasthenia gravis.
    Chan KH; Lachance DH; Harper CM; Lennon VA
    Muscle Nerve; 2007 Nov; 36(5):651-8. PubMed ID: 17654558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoglobulins in myasthenia gravis. Kinetic properties of the acetylcholine-receptor antibody studied during lymph drainage.
    Lefvert AK
    Clin Exp Immunol; 1978 Oct; 34(1):111-7. PubMed ID: 750115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of TE671 cells in the detection of anti-acetylcholine receptor antibodies].
    Kennel P; Vilquin JT; Fonteneau P; Tranchant C; Poindron P; Warter JM
    Rev Neurol (Paris); 1993; 149(12):771-5. PubMed ID: 7997736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [ELISA for detection of anti-filamin antibody in sera from patient with myasthenia gravis].
    Lin H
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Oct; 25(5):281-3, 316-7. PubMed ID: 1291249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
    Caress JB; Hunt CH; Batish SD
    Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Almon RR; Levy N
    N Engl J Med; 1975 Oct; 293(15):760-1. PubMed ID: 1160955
    [No Abstract]   [Full Text] [Related]  

  • 33. Serological follow-up in juvenile myasthenia: clinical and acetylcholine receptor antibody status of patients followed for at least 2 years.
    Anlar B; Senbil N; Köse G; Değerliyurt A
    Neuromuscul Disord; 2005 May; 15(5):355-7. PubMed ID: 15833428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical significance of immune complexes at the motor endplate in myasthenia gravis].
    Tsujihata M; Yoshimura T; Satoh A; Hazama R; Mori M
    Rinsho Shinkeigaku; 1983 Sep; 23(9):735-43. PubMed ID: 6673871
    [No Abstract]   [Full Text] [Related]  

  • 35. Acetylcholine receptor antibodies in the diagnosis and management of myasthenia gravis.
    Nicholson GA; Griffiths LR
    Clin Exp Neurol; 1981; 18():61-9. PubMed ID: 6926393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High interleukin-10 production is associated with anti-acetylcholine receptor antibody production and treatment response in juvenile myasthenia gravis.
    Yapici Z; Tüzün E; Altunayoğlu V; Erdoğan A; Eraksoy M
    Int J Neurosci; 2007 Nov; 117(11):1505-12. PubMed ID: 17917921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fundamental studies with respect to plasma exchange by using continuous-flow centrifuge system and the clinical trial in patients with myasthenia gravis].
    Suga M; Akahonai Y; Tsujisaki M; Mori M; Yoshizaki H; Matsumoto H; Yachi A
    Hokkaido Igaku Zasshi; 1982 Nov; 57(6):734-40. PubMed ID: 7183499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A radioimmunoassay for the quantitative evaluation of anti-human acetylcholine receptor antibodies in myasthenia gravis.
    Monnier VM; Fulpius BW
    Clin Exp Immunol; 1977 Jul; 29(1):16-22. PubMed ID: 891031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Properties and serum levels of specific populations of anti-acetylcholine receptor antibodies in myasthenia gravis.
    Fulpius BW; Lefvert AK; Cuénoud S; Mourey A
    Ann N Y Acad Sci; 1981; 377():307-15. PubMed ID: 6951478
    [No Abstract]   [Full Text] [Related]  

  • 40. [Heterogeneity of acetylcholine receptor antibodies in patients with myasthenia gravis].
    Kalies I; Heinz F; Kaschka WP; Druschky KF; Kalden JR
    Klin Wochenschr; 1984 Apr; 62(8):377-85. PubMed ID: 6727277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.